Run2021.01 ROS1

Disease Application:
  • Non-small Cell Lung Cancer (NSCLC)
Test Performance Characteristics:
  • EQA Accuracy
  • Analytical Sensitivity (measured LOD)
  • Descriptive Analytical Sensitivity
Techniques:
  • IHC
Sample Information:
  • Cell lines, calibrators, and tissue microarrays
Samples for this run will start shipping to laboratories:
  • June 2021
The run results from each laboratory must be submitted to CBQA by:
  • 30 June 2021
The current status for this run:
  • Run Completed

Please see our other schemes as this run has ended

Enrollment Deadline : June 2021